Cargando…
A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples
SARS-CoV-2, a novel human coronavirus, has created a global disease burden infecting > 100 million humans in just over a year. RT-PCR is currently the predominant method of diagnosing this viral infection although a variety of tests to detect viral antigens have also been developed. In this study...
Autores principales: | Mangalaparthi, Kiran K., Chavan, Sandip, Madugundu, Anil K., Renuse, Santosh, Vanderboom, Patrick M., Maus, Anthony D., Kemp, Jennifer, Kipp, Benjamin R., Grebe, Stefan K., Singh, Ravinder J., Pandey, Akhilesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532087/ https://www.ncbi.nlm.nih.gov/pubmed/34686148 http://dx.doi.org/10.1186/s12014-021-09331-z |
Ejemplares similares
-
Correction: A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples
por: Mangalaparthi, Kiran K., et al.
Publicado: (2022) -
Comparison of anti-peptide and anti-protein antibody-based purification techniques for detection of SARS-CoV-2 by targeted LC-MS/MS
por: Maus, Anthony, et al.
Publicado: (2022) -
A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens
por: Renuse, Santosh, et al.
Publicado: (2021) -
Targeted Detection
of SARS-CoV-2 Nucleocapsid
Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides
por: Maus, Anthony, et al.
Publicado: (2021) -
Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx
por: Vanderboom, Patrick M., et al.
Publicado: (2021)